Pain & Perception: Reducing nerve injury risks is organized by Alaska Dental Society (ADS) and will be held on Nov 19, 2020 at Hilton Anchorage, Anchorage, Alaska, United States of America. Accrditation: • 3.0 ADA CERP credits Description: The Dentists Insurance Company's claims experience reveals that nerve injury claims resulting from extraction, endodontic treatment, implant placement and other invasive procedures rate among the highest in severity and frequency. The Dentists Insurance Company’s new Risk Management seminar is designed to build your confidence in these interactions. Participate in the Pain & Perception seminar and learn how to: • Institute communication protocols when multiple dentists are involved in treatment. • Recognize the importance of complete and appropriate documentation. • Communicate unexpected treatment outcomes to patients and know when to refer. • Understand that informed consent is a process, not a form. Additional details will be posted as soon as information is available.

Alaska Pharmacists Association (AKPhA) 55th Annual Convention & Tradeshow, 2021 is organized by Alaska Pharmacists Association (AKPhA) and will be held from Feb 12 - 14, 2021 at Hilton Anchorage, Anchorage, Alaska, United States of America. Additional details will be posted as soon as information is available.

Current Topics in Anesthesia is organized by Northwest Seminars (NWS) and will be held from Jul 05 - 09, 2021 at The Lakefront Anchorage, Anchorage, Alaska, United States of America. Target Audience: This course is designed for physicians, certified registered nurse anesthetists, physician assistants, nurse practitioners, registered nurses and other medical care providers who must maintain state-of-the-art knowledge of the anesthesia specialty or are impacted by it. Accreditation: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 24 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Registered Nurses:  NWAS is an approved provider for the following state nursing boards: Arkansas State Board of Nursing (Provider Number 50-7480), California Board of Registered Nursing (Provider Number 4833), District of Columbia Board of Nursing (Provider Number 50-7480), Florida Board of Nursing (Provider Number 50-7480), Georgia Board of Nursing (Provider Number 50-7480), and the South Carolina Board of Nursing (Provider Number 50-7480). This program offers 24 contact hours. Certified Registered Nurse Anesthetists:  This program has been prior approved by the American Association of Nurse Anesthetists for 24 Class A CE; Code Number 1037991; Expiration Date 7/9/2021. Physician Assistants:  The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 24 hours of Category I credit for completing this program. Program Purpose: The practitioner of anesthesiology must possess the scientific background for clinical practice; maintain state-of-the-art knowledge of not only the specialty, but also of all additional related disciplines which may impact it; maintain an up-to-the-minute armamentarium of knowledge and skills for the selection and use of complex equipment, pharmacological agents, and procedures necessary for the provision of quality patient care; manage self and colleagues to function toward common goals in the clinical setting, the clinical and educational institutions, and the community in which the practice resides; serve as an expert in matters involving health care delivery; serve as an informed manager of clinical and educational services provided, including the acquisition and distribution of resources necessary in meeting professional goals; and provide assistance with and support of other service providers, departments, institutions, and organizations dependent upon the professional expertise of the practitioner. Presentations are designed to facilitate the healthcare provider in reviewing, updating, and/or expanding knowledge and abilities in one or more of these areas vital to the practicing professional. Objectives: At the conclusion of this activity, the participant will be able to: • Apply the pertinent physical and behavioral sciences - to include but not be limited to advanced anatomy and physiology, pathophysiology, chemistry, physics, psychology, and social sciences - as they impact and are affected by the planning, delivery, and monitoring of anesthesia and related services inherent in the anesthesia professions. • Explain the selection, dosing considerations with methods of administration, safe use, and contraindications and precautions of presented pharmacological agents through the understanding of their physico-chemical properties, pharmacokinetics and pharmacodynamics, updated uses, and more recently developed additional, related, and similar drugs. • Outline comprehensive management plans for the group of patients discussed, whether related in age, physical status, cultural background, invasive procedure, anesthetic or analgesic requirements, clinical setting, adverse reactions, and/or goals of care. • Apply the principles of safety and asepsis in the performance of anesthetic procedures and administrations, equipment use, and other applications encountered during the provision of anesthesia and analgesia whether in the surgical unit, the labor and delivery suite, the pain management clinic, or other more remote location of anesthetizing services. • Incorporate the appropriate recommendations and/or requirements of pertinent external organizations, institutions, and professional groups - recognized as serving as the authority for and/or holding the responsibility to compile and approve such tenets - in the provision of anesthesia and related services, whether medical, legal, philosophical, ethical, or health care management standards.

Echo Alaska: Frontiers of Multimodality Imaging Including Echo, Cardiac CT and MRI is organized by Mayo Clinic Cardiovascular Medicine CME (CV CME) and will be held from Jul 19 - 23, 2021 at Sheraton Anchorage Hotel & Spa, Anchorage, Alaska, United States of America. Target Audience: This conference is specifically designed for adult and congenital cardiovascular specialists, internists, anesthesiologists, critical care physicians, surgeons, and sonographers interested in the clinical application of echocardiography, cardiac CT, and MRI. Course Description: This symposium is a comprehensive review of state-of-the-art echocardiography, cardiac CT, and MRI for a wide variety of cardiovascular disorders. We will emphasize new technologies and how to use imaging information for the care of your patients. Integration of echo, CT, and MRI and their incremental value in clinical cardiology will be highlighted. An additional focus will be on the role of 2-D and 3-D echocardiography in guiding interventional therapies. Unique to this course is live scanning of patients with various cardiovascular disorders. This session will emphasize the importance of comprehensive echocardiographic acquisition and management decision based on echocardiographic data.  Course Highlights: • Imaging in echo, cardiac CT and MRI • Strain imaging • Congenital heart disease • Amyloid • 3-D TEE • Live scanning sessions • Hands-on scanning opportunity Course Objectives: Upon completion of this program, attendees should be able to: • Describe applications of echocardiography, cardiac CT, and MRI to clinical decision-making • Integrate Doppler, 2-D, 3-D echocardiography for management of patients with valvular heart disease • Describe how to apply information from Doppler, 2-D, and strain imaging to management of patients with cardiomyopathy and heart failure patients including heart failure with preserved EF • Integrate information from cardiac CT and MRI to compliment echocardiography evaluation of patients with valvular disease, cardiomyopathy, and heart failure • Apply information from echo/Doppler, cardiac CT, and MRI to management of patients with congenital heart disease • Describe how to critically appraise imaging data for use in case-based management • Assess treatment strategies for cardiomyopathies including amyloidosis and hypertrophic cardiomyopathy Additional details will be posted as soon as information is available.